Research programme: cocaine antagonists - Guilford
Alternative Names: Cocaine antagonists research programme - Guilford PharmaceuticalsLatest Information Update: 03 Jan 2001
At a glance
- Originator MGI GP
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cocaine-related disorders
Most Recent Events
- 03 Jan 2001 Discontinued-Preclinical for Cocaine abuse in USA (Unknown route)
- 11 Jan 1999 Preclinical development for Cocaine abuse in USA (Unknown route)
- 26 Mar 1998 New profile